PTCT NASDAQ
PTC Therapeutics, Inc.
1W: -4.0%
1M: -1.5%
3M: -1.2%
YTD: -9.1%
1Y: +47.9%
3Y: +28.8%
5Y: +83.7%
$68.81
-0.98 (-1.40%)
Weekly Expected Move ±9.4%
$58
$65
$71
$78
$85
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$827M
Revenue
-53.3% YoY
$-187M
Net Income
-131.4% YoY
$-229M
Free Cash Flow
-133.7% YoY
85.5%
Gross Margin
16.8%
Op. Margin
-1.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE28.7%
ROA-8.1%
ROIC3.2%
Valuation
P/E-30.3
P/B-31.4
EV/EBITDA-188.0
Leverage
Debt/Equity-2.40
Current Ratio2.35
Interest Cov.-1.0x
Quality Scores
Piotroski F2/9
Altman Z0.40
Beneish M0.24